As AI takes a more prominent space in our lives and workplaces, it's essential that we protect our cognitive real estate (and ...

Crizanlizumab (Adakveo) failed to outperform placebo in patients with sickle cell disease, the phase III STAND trial showed.

Catarina Craveiro, a biomedical research technician from Lisbon, had been hobbled by lower back pain from scoliosis since ...

The Food and Drug Administration (FDA) has accepted for Priority Review the supplemental New Drug Application (sNDA) for finerenone for the treatment of ...

The following is a summary of “A systematic review and meta-analysis of the response to placebo in clinical trials of ...

Remibrutinib results in significant improvement in patients still symptomatic after second-generation H1-antihistamine treatment.